[1] CHEN G M,CHEN Z H. Effect evaluation of rosiglitazone sodium added to type 2 diabetes with poor glycemic [J]. Guangzhou Med J(广州医药),2006,37(3):23-24.
[2] ZHOU H J. Internation Conference on Harmonisation of Technical Requirements for Registration of Pharmceuticals for Human Use, Quality Section(ICH药品注册的国际技术要求,质量部分)[M]. Beijing:People’s Medical Publishing House,2000.
[3] ZHENG G G,FANG Y Z. RP-HPLC Determination of content and its related substances of rosiglitazone[J]. Chin J Pharm Anal(药物分析杂志),2005,25(1):104-106.